Clinical trials
Active, not recruiting Phase 2 Lymphoma, Non-Hodgkin trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
35 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2009 | 2 |
| 2012 | 1 |
| 2013 | 1 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 3 |
| 2018 | 6 |
| 2019 | 5 |
| 2020 | 4 |
| 2021 | 3 |
| 2022 | 4 |
| 2023 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 35 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 9 |
| City of Hope Medical Center | 3 |
| St. Jude Children's Research Hospital | 3 |
| Genmab | 2 |
| Actuate Therapeutics Inc. | 1 |
| Celgene | 1 |
| Cellectar Biosciences, Inc. | 1 |
| Cothera Bioscience, Inc | 1 |
| Divaya Bhutani | 1 |
| Eli Lilly and Company | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma, Non-Hodgkin | 35 |
| Ependymoma | 9 |
| Glioma | 9 |
| Medulloblastoma | 9 |
| Neuroblastoma | 9 |
| Hepatoblastoma | 8 |
| Histiocytosis, Langerhans-Cell | 8 |
| Hodgkin Disease | 8 |
| Neuroectodermal Tumors, Primitive, Peripheral | 8 |
| Osteosarcoma | 8 |
Trials
Showing 1 to 25 of 35. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.